Modulation of protein kinase signaling by protein phosphatases and inhibitors

Zhong-Yin Zhang, Bo Zhou, Laiping Xie

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Protein tyrosine phosphatases (PTPs) form a large family of enzymes that serve as key regulatory components in signal transduction pathways. Defective or inappropriate regulation of PTP activity leads to aberrant tyrosine phosphorylation, which contributes to the development of many human diseases. In addition to controlling the phosphorylation states of protein kinase substrates, PTPs can also directly modulate protein kinase activity. Evidence suggests that PTPs can exert both positive and negative effects on a signaling pathway. Thus, further understanding of the fundamental role of protein tyrosine phosphorylation in complex and critical signal transduction pathways requires detailed studies of both the kinases and the phosphatases. In this review, we first summarize our current understanding of PTP structure and function. We then discuss the molecular basis of PTP substrate specificity, focusing primarily on mitogen-activated protein (MAP) kinase phosphatase 3. We demonstrate that the MAP kinase phosphatases display exquisite substrate specificity requiring extensive protein-protein interactions for precise down-regulation of MAP kinase activity. We also highlight our recent progress in developing small molecule PTP1B inhibitors. Using a novel combinatorial approach that is designed to target both the active site and a unique peripheral site in PTP1B, we have obtained a PTP1B inhibitor with 2.4 nM affinity and orders of magnitude selectivity against a panel of PTPs. Currently, some of the compounds are being evaluated in both cell and animal models to further define the role of PTP1B in insulin signaling.

Original languageEnglish (US)
Pages (from-to)307-317
Number of pages11
JournalPharmacology and Therapeutics
Volume93
Issue number2-3
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Protein Tyrosine Phosphatases
Phosphoprotein Phosphatases
Protein Kinases
Phosphorylation
Substrate Specificity
Dual Specificity Phosphatase 6
Tyrosine
Signal Transduction
Mitogen-Activated Protein Kinase Phosphatases
Proteins
Human Development
Mitogen-Activated Protein Kinases
Phosphoric Monoester Hydrolases
Catalytic Domain
Phosphotransferases
Down-Regulation
Animal Models
Insulin
Enzymes

Keywords

  • Inhibitor development
  • MKP3
  • Protein phosphorylation
  • PTP
  • PTP1B
  • Substrate specificity

ASJC Scopus subject areas

  • Pharmacology

Cite this

Modulation of protein kinase signaling by protein phosphatases and inhibitors. / Zhang, Zhong-Yin; Zhou, Bo; Xie, Laiping.

In: Pharmacology and Therapeutics, Vol. 93, No. 2-3, 2002, p. 307-317.

Research output: Contribution to journalArticle

@article{47da715c110c42ae92bcb43281a3166f,
title = "Modulation of protein kinase signaling by protein phosphatases and inhibitors",
abstract = "Protein tyrosine phosphatases (PTPs) form a large family of enzymes that serve as key regulatory components in signal transduction pathways. Defective or inappropriate regulation of PTP activity leads to aberrant tyrosine phosphorylation, which contributes to the development of many human diseases. In addition to controlling the phosphorylation states of protein kinase substrates, PTPs can also directly modulate protein kinase activity. Evidence suggests that PTPs can exert both positive and negative effects on a signaling pathway. Thus, further understanding of the fundamental role of protein tyrosine phosphorylation in complex and critical signal transduction pathways requires detailed studies of both the kinases and the phosphatases. In this review, we first summarize our current understanding of PTP structure and function. We then discuss the molecular basis of PTP substrate specificity, focusing primarily on mitogen-activated protein (MAP) kinase phosphatase 3. We demonstrate that the MAP kinase phosphatases display exquisite substrate specificity requiring extensive protein-protein interactions for precise down-regulation of MAP kinase activity. We also highlight our recent progress in developing small molecule PTP1B inhibitors. Using a novel combinatorial approach that is designed to target both the active site and a unique peripheral site in PTP1B, we have obtained a PTP1B inhibitor with 2.4 nM affinity and orders of magnitude selectivity against a panel of PTPs. Currently, some of the compounds are being evaluated in both cell and animal models to further define the role of PTP1B in insulin signaling.",
keywords = "Inhibitor development, MKP3, Protein phosphorylation, PTP, PTP1B, Substrate specificity",
author = "Zhong-Yin Zhang and Bo Zhou and Laiping Xie",
year = "2002",
doi = "10.1016/S0163-7258(02)00199-7",
language = "English (US)",
volume = "93",
pages = "307--317",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",
number = "2-3",

}

TY - JOUR

T1 - Modulation of protein kinase signaling by protein phosphatases and inhibitors

AU - Zhang, Zhong-Yin

AU - Zhou, Bo

AU - Xie, Laiping

PY - 2002

Y1 - 2002

N2 - Protein tyrosine phosphatases (PTPs) form a large family of enzymes that serve as key regulatory components in signal transduction pathways. Defective or inappropriate regulation of PTP activity leads to aberrant tyrosine phosphorylation, which contributes to the development of many human diseases. In addition to controlling the phosphorylation states of protein kinase substrates, PTPs can also directly modulate protein kinase activity. Evidence suggests that PTPs can exert both positive and negative effects on a signaling pathway. Thus, further understanding of the fundamental role of protein tyrosine phosphorylation in complex and critical signal transduction pathways requires detailed studies of both the kinases and the phosphatases. In this review, we first summarize our current understanding of PTP structure and function. We then discuss the molecular basis of PTP substrate specificity, focusing primarily on mitogen-activated protein (MAP) kinase phosphatase 3. We demonstrate that the MAP kinase phosphatases display exquisite substrate specificity requiring extensive protein-protein interactions for precise down-regulation of MAP kinase activity. We also highlight our recent progress in developing small molecule PTP1B inhibitors. Using a novel combinatorial approach that is designed to target both the active site and a unique peripheral site in PTP1B, we have obtained a PTP1B inhibitor with 2.4 nM affinity and orders of magnitude selectivity against a panel of PTPs. Currently, some of the compounds are being evaluated in both cell and animal models to further define the role of PTP1B in insulin signaling.

AB - Protein tyrosine phosphatases (PTPs) form a large family of enzymes that serve as key regulatory components in signal transduction pathways. Defective or inappropriate regulation of PTP activity leads to aberrant tyrosine phosphorylation, which contributes to the development of many human diseases. In addition to controlling the phosphorylation states of protein kinase substrates, PTPs can also directly modulate protein kinase activity. Evidence suggests that PTPs can exert both positive and negative effects on a signaling pathway. Thus, further understanding of the fundamental role of protein tyrosine phosphorylation in complex and critical signal transduction pathways requires detailed studies of both the kinases and the phosphatases. In this review, we first summarize our current understanding of PTP structure and function. We then discuss the molecular basis of PTP substrate specificity, focusing primarily on mitogen-activated protein (MAP) kinase phosphatase 3. We demonstrate that the MAP kinase phosphatases display exquisite substrate specificity requiring extensive protein-protein interactions for precise down-regulation of MAP kinase activity. We also highlight our recent progress in developing small molecule PTP1B inhibitors. Using a novel combinatorial approach that is designed to target both the active site and a unique peripheral site in PTP1B, we have obtained a PTP1B inhibitor with 2.4 nM affinity and orders of magnitude selectivity against a panel of PTPs. Currently, some of the compounds are being evaluated in both cell and animal models to further define the role of PTP1B in insulin signaling.

KW - Inhibitor development

KW - MKP3

KW - Protein phosphorylation

KW - PTP

KW - PTP1B

KW - Substrate specificity

UR - http://www.scopus.com/inward/record.url?scp=0035990925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035990925&partnerID=8YFLogxK

U2 - 10.1016/S0163-7258(02)00199-7

DO - 10.1016/S0163-7258(02)00199-7

M3 - Article

VL - 93

SP - 307

EP - 317

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

IS - 2-3

ER -